None
Quote | ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Last: | $20.80 |
---|---|
Change Percent: | -0.05% |
Open: | $20.84 |
Close: | $20.80 |
High: | $20.84 |
Low: | $20.8 |
Volume: | 1,501 |
Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Summary TAMS for Non-Alcoholic Steatohepatitis NASH after topline PH2a results and what it could mean to Cytodyn long term investors. Wall Street modeling of non-revenue generating biotechs. Headwinds and risks involved. Overview CytoDyn Inc. (CYDY) is a Vanc...
Summary Toripalimab approval will be decided for Coherus at the end of December. Cimerli approval has pushed up the stock. However, the tori PDUFA is the major catalytic event here. It is interesting to see that despite its foray into original R&D through a Chine...
Message Board Posts | ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)
Subject | By | Source | When |
---|---|---|---|
yes agree I am in at .105 and | otc1investor | investorshub | 02/08/2017 9:25:40 PM |
Just want to take a selfie sometimes :)!!! | Deep Space | investorshub | 01/10/2016 2:12:26 PM |
$BIS recent news/filings | stocktrademan | investorshub | 12/17/2015 8:52:16 PM |
$BIS recent news/filings | stocktrademan | investorshub | 09/28/2015 6:26:24 PM |
Looks good.Good short and patient long deals popping | Deep Space | investorshub | 08/11/2015 4:40:53 PM |